Background
Cervical cancer is a long-term outcome of persistent human papillomavirus (HPV) infection of the lower genital tract, with one of the 15 high-risk HPV types being “necessary” for cervical cancer.1,2 Globally, 661,021 cases of cervical cancer and 348,189 deaths are reported annually, making 4th most common cancer among women, with majority of cases coming from low- and middle-income countries, mostly Sub-Saharan Africa.3 It is the most are common cancer in Ugandan women, with an incidence rate of 54.8 per 100,000 women per year.4 Women Living with Human Immune Virus (HIV) have a shorter period from HPV acquisition to invasive cervical lesions and therefore have a higher risk of cervical cancer than HIV negative women.5 The World Health Organization, (WHO), targets having 90% of girls fully vaccinated…